NCT00612001View on ClinicalTrials.gov

Vaccine Therapy in Treating Patients With Malignant Glioma

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

January 31, 2011

Study Completion Date

October 31, 2012

Conditions
Brain and Central Nervous System Tumors
Interventions
BIOLOGICAL

glioma-associated antigen peptide-pulsed autologous dendritic cell vaccine

Trial Locations (1)

90095-1781

Jonsson Comprehensive Cancer Center at UCLA, Los Angeles

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Jonsson Comprehensive Cancer Center

OTHER

NCT00612001 - Vaccine Therapy in Treating Patients With Malignant Glioma | Biotech Hunter | Biotech Hunter